Chen-jee Y. Hong

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression.

Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression.

Journal: Journal of psychopharmacology (Oxford, England)

Published: March 25, 2025

Interleukin-4 inhibits the hypothalamic appetite control by modulating the insulin-AKT and JAK-STAT signaling in leptin mutant mice.

Interleukin-4 inhibits the hypothalamic appetite control by modulating the insulin-AKT and JAK-STAT signaling in leptin mutant mice.

Journal: Environmental toxicology

Published: November 20, 2023

Abnormalities of Hippocampal Subfield and Amygdalar Nuclei Volumes and Clinical Correlates in Behavioral Variant Frontotemporal Dementia with Obsessive-Compulsive Behavior-A Pilot Study.

Abnormalities of Hippocampal Subfield and Amygdalar Nuclei Volumes and Clinical Correlates in Behavioral Variant Frontotemporal Dementia with Obsessive-Compulsive Behavior-A Pilot Study.

Journal: Brain sciences

Published: September 24, 2023

Exploring the Effectiveness of Group Cognitive Stimulation Training in People With Schizophrenia: A Randomized Controlled Trial.

Exploring the Effectiveness of Group Cognitive Stimulation Training in People With Schizophrenia: A Randomized Controlled Trial.

Journal: The journal of nursing research : JNR

Published: September 19, 2023

Effect of low-frequency repetitive transcranial magnetic stimulation as adjunctive treatment for insomnia patients under hypnotics: A randomized, double-blind, sham-controlled study.

Effect of low-frequency repetitive transcranial magnetic stimulation as adjunctive treatment for insomnia patients under hypnotics: A randomized, double-blind, sham-controlled study.

Journal: Journal of the Chinese Medical Association : JCMA

Published: March 31, 2023

Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.

Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.

Journal: CNS drugs

Published: January 15, 2023

Rechallenge with Amisulpride in a Patient with Schizophrenia following a Manic Episode during Previous Therapy.

Rechallenge with Amisulpride in a Patient with Schizophrenia following a Manic Episode during Previous Therapy.

Journal: Case reports in psychiatry

Published: January 08, 2022

Corrigendum to "Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study" [Genomics. 2021 Mar;113(2):507-514].

Corrigendum to "Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study" [Genomics. 2021 Mar;113(2):507-514].

Journal: Genomics

Published: November 15, 2021

Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.

Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.

Journal: Pharmacopsychiatry

Published: September 16, 2021

Predictive roles of brain-derived neurotrophic factor Val66Met polymorphism on antidepressant efficacy of different forms of prefrontal brain stimulation monotherapy: A randomized, double-blind, sham-controlled study.

Predictive roles of brain-derived neurotrophic factor Val66Met polymorphism on antidepressant efficacy of different forms of prefrontal brain stimulation monotherapy: A randomized, double-blind, sham-controlled study.

Journal: Journal of affective disorders

Published: August 16, 2021

Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.

Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.

Journal: Human psychopharmacology

Published: July 09, 2021

Low-dose ketamine infusion for treating subjective cognitive, somatic, and affective depression symptoms of treatment-resistant depression.

Low-dose ketamine infusion for treating subjective cognitive, somatic, and affective depression symptoms of treatment-resistant depression.

Journal: Asian journal of psychiatry

Published: July 04, 2021

Showing 1-12 of 63

Last Updated: 09/26/2026